WallStSmart
ANTX

AN2 Therapeutics Inc

NASDAQ: ANTX · HEALTHCARE · BIOTECHNOLOGY

$4.68
-1.27% today

Updated 2026-04-29

Market cap
$156.22M
P/E ratio
P/S ratio
EPS (TTM)
$-1.16
Dividend yield
52W range
$1 – $7
Volume
1.7M

AN2 Therapeutics Inc (ANTX) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+28.3%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+100.0%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-10.7%
Last 3 reports
Positive reaction rate
0%
0 of 3 quarters
Largest single-day move
-21.8%
2026-03-18
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-04-01$0.00+100.0%$3.42$3.27-4.4%
2026-03-18$-0.29-20.8%$5.00$3.91-21.8%
2025-11-12$-0.31+1.6%$1.20$1.13-5.8%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2026-03-31$-0.22$0.00+100.0%
2025-12-31$-0.24$-0.29-20.8%
2025-09-30$-0.32$-0.31+1.6%
2025-06-30$-0.31$-0.21+32.3%
2025-03-31$-0.25$-0.35-40.0%
2024-12-31$-0.27$-0.25+7.4%
2024-09-30$-0.45$-0.43+4.4%
2024-06-30$-0.61$-0.48+21.3%
2024-03-31$-0.62$-0.56+9.7%$80000.00
2023-12-31$-0.75$-0.57+24.0%$80000.00
2023-09-30$-0.63$-0.65-3.2%

Frequently asked questions

Has AN2 Therapeutics Inc beaten earnings estimates?
AN2 Therapeutics Inc has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +28.3% over the last 4 quarters.
How does ANTX stock react to earnings?
ANTX stock has moved an average of -10.7% in the trading day following earnings over its last 3 reports, with positive reactions in 0% of those quarters.